Genetic Testing for Huntington’s Disease: What the HTT Result Means for Planning Care

She is 29, and the phone call comes on an ordinary Tuesday. Her father, who has been dropping things and snapping at people for two years, finally has a name for it. Huntington’s disease. By the time she hangs up she has already done the arithmetic that every child of a parent with this condition does: a coin flip. Heads, she carries the gene. Tails, she does not. The coin was tossed before she was born; the test only reveals which way it landed.

That is the strange shape of Huntington’s disease genetic testing. Most medical tests tell you about now. This one tells you about a future that may be decades away, and it tells you with a precision that almost no other predictive test can match. People who go through it describe the result less as information and more as a change in the weather of their lives.

What follows is an honest account of what the test measures, what the number on the report does and does not mean, who is usually offered it and who is asked to wait, and how a result becomes a plan rather than a verdict.

Can genetic testing detect Huntington's disease?

Yes, and with unusual clarity. Huntington’s disease is caused by a change in a single gene, called HTT, which carries the instructions for a protein named huntingtin (MedlinePlus Genetics). Inside that gene sits a short stretch of DNA where three chemical letters, cytosine, adenine and guanine, repeat one after another. Scientists call this a CAG repeat. Everyone has it. The question is how many times it repeats.

In most people the sequence repeats between 10 and 35 times. In people who develop Huntington’s disease it repeats 36 times or more, and in the great majority of affected people it repeats 40 or more times (MedlinePlus Genetics). The extra repeats produce a longer, misshapen version of the huntingtin protein, which clumps inside nerve cells and gradually damages them, particularly in a deep brain region called the striatum that helps coordinate movement, mood and thinking.

Because one gene and one kind of change account for the condition, a single laboratory test can measure it. The lab extracts DNA from a blood sample, copies the relevant stretch of the HTT gene many times over, and measures the length of the product. Each person has two copies of the gene, one from each parent, so the report shows two numbers, for example 17 and 42. The larger number is the one that matters.

This is why the test is sometimes described as definitive in a way that most genetic tests are not. There is no gray zone about whether the gene is involved. The only gray zones are the narrow band of 36 to 39 repeats, discussed below, and the far larger question of what a positive number means for the years ahead. The laboratory can count. It cannot forecast.

How is Huntington's disease inherited?

Huntington’s disease follows an autosomal dominant pattern. That phrase means two things in plain language: the gene sits on one of the 22 numbered chromosomes rather than a sex chromosome, so it affects men and women equally, and a single expanded copy is enough to cause the disease. A person with the expansion has one expanded copy and one typical copy, and each child inherits one of the two at random. The chance of passing on the expansion is therefore 50 percent with every pregnancy (MedlinePlus Genetics; NHS).

That 50 percent is a probability, not a quota. Three children can all inherit it; three can all be spared. Each pregnancy is a fresh toss of the same coin.

Two features of the inheritance surprise families. The first is that the disease does not skip generations in the true sense. If someone carries the expansion, one of their parents almost always carried it too, even if that parent died young of something else or developed symptoms so late that nobody connected them. The second is a phenomenon called anticipation. The CAG repeat is unstable when it is copied into sperm and, less often, eggs, and it tends to lengthen rather than shorten. A longer repeat is linked, on average, to earlier onset. This instability is more pronounced when the gene is inherited from the father, which is why the juvenile form of the disease more often comes through the paternal line (MedlinePlus Genetics).

The condition is rare. Estimates in populations of European ancestry run at roughly 3 to 7 affected people per 100,000, and it appears less common in people of Japanese, Chinese and African descent (MedlinePlus Genetics). Rarity is part of why a family history can go unrecognized for a generation or more.

Huntington's disease CAG repeats: what the number on the report means

The report comes back with two numbers. Genetic counselors tend to interpret them using four bands, and understanding those bands before the appointment makes the conversation far less bewildering.

CAG repeats (larger allele)	Category	What it generally means
26 or fewer	Normal	Not associated with Huntington’s disease; stable when passed to children
27 to 35	Intermediate	Person will not develop the disease, but the repeat can expand when passed on, so a child could land in the disease range
36 to 39	Reduced penetrance	Person may or may not develop symptoms; onset, when it occurs, is often later in life
40 or more	Full penetrance	Person will develop Huntington’s disease within a typical lifespan

These thresholds are drawn from MedlinePlus Genetics and are the ones used in clinical laboratories. A few points deserve emphasis. Penetrance is the proportion of people with a gene change who actually develop the condition. Full penetrance at 40 repeats and above means the question is when, not whether. Reduced penetrance between 36 and 39 means some people live a full life without symptoms, and nobody can yet say in advance who they will be.

The intermediate band is the one that catches people off guard. A person with 33 repeats is not at risk themselves, but because the repeat can lengthen as it is copied into sperm or eggs, their child could inherit 36 or more. That is how a family with no known history occasionally sees a first case.

One more thing the table cannot show: within the full-penetrance range, a higher count is associated with earlier onset on average, but the spread is wide. Two people with identical counts can differ by many years in when symptoms begin. The number is a direction, not a date.

What actually happens during Huntington's disease genetic testing

The blood draw is the shortest part. Almost everything else is conversation, and that is by design.

The process begins with a referral to a genetics service or a neurology team that specializes in the condition. The first appointment is a genetic counseling session. A genetic counselor is a health professional trained in both inheritance and the psychology of risk. In that session the counselor takes a detailed family history, draws a family tree, confirms the diagnosis in the affected relative where possible, and explains how the test works and what each result would mean. Many services ask people to attend more than one session before deciding, so that the decision is made in a settled frame of mind rather than in the shock of a parent’s diagnosis (NHS).

People are encouraged to bring a partner, friend or relative, and to think about who will be with them on the day results are given. Some services also offer a neurological examination before predictive testing, so that a baseline exists and so that anyone who already has subtle signs understands that their result would be diagnostic rather than predictive.

When the person is ready, a blood sample is taken. Results typically take a few weeks to return (NHS). They are given in person, by the counselor or clinician, never by letter or phone, and a follow-up appointment is arranged whatever the outcome.

Consent is formal and specific. The person signs to say they understand that the result cannot be undone, that it has implications for blood relatives, and that they may stop the process at any point. People do stop. Some get as far as the blood draw and ask the lab not to run it, and that is treated as an entirely legitimate choice.

Who is predictive testing usually for, and who is usually asked to wait

Predictive testing, meaning testing in someone who has no symptoms but has an affected parent or grandparent, is offered to adults who have thought it through and want to know. That usually means someone aged 18 or over, attending by their own choice, with a confirmed diagnosis in the family and access to support afterward.

Several groups are generally asked to wait, or are not tested at all.

• Children and teenagers without symptoms. Predictive testing is not usually offered under the age of 18 (NHS). The reasoning is that the result would arrive years before any symptom, removing the young person’s right to decide for themselves as an adult, and offering no medical benefit in childhood. A child who has clear symptoms is a different case and may be tested diagnostically.
• People in acute distress. Someone in the middle of a depressive episode, a bereavement or a relationship crisis is often asked to let that settle first. The test will still be there.
• People being pressured. If a partner, employer or relative is driving the request, counselors slow the process down. The decision has to belong to the person whose blood is being drawn.
• People who have not yet confirmed the family diagnosis. Where records are unavailable, counselors try to establish that the relative truly had Huntington’s disease before testing a descendant.

Choosing not to test is common and is treated as a complete decision, not a postponed one. Many at-risk adults live their whole lives without finding out, and some who said no at 25 say yes at 40 when they want to plan a family or notice a change in themselves. Services are built to accommodate both paths.

Predictive, diagnostic and prenatal testing: how they differ

The same laboratory test serves three quite different purposes, and the purpose changes everything about how it is used.

Diagnostic testing is done in someone who already has symptoms that suggest the disease. Here the test confirms what a neurologist suspects, and the counseling is about the diagnosis and what comes next. The result also carries information for relatives, who learn that they are now at 50 percent risk.

Predictive testing is done in an adult without symptoms. The medical facts are the same, but the ethics are different because the person is well and will remain so for an unknown period. This is where the multi-session counseling model described above comes from.

Prenatal testing is offered to couples where one partner carries the expansion and a pregnancy is underway. A sample of placental tissue or amniotic fluid is tested, usually in the first or second trimester, and the couple decides how to proceed with that information (NHS). Because the result also reveals the status of the at-risk parent if that parent has never been tested, services counsel carefully about this beforehand.

Preimplantation genetic testing is an alternative that uses IVF. Embryos are created outside the body, a few cells from each are tested, and only unaffected embryos are transferred (NHS). It allows a couple to avoid passing on the expansion without a prenatal diagnosis during pregnancy.

A less well-known option is exclusion testing. A person who does not want to learn their own status can still have a pregnancy tested to see whether the fetus inherited the HTT region from the affected grandparent. If not, the fetus is not at risk; if so, the fetus carries the same 50 percent risk as the parent, and the parent’s own status remains unknown. Which route suits a family is a conversation for the genetics team, not a question with one right answer.

Is the HTT test the gold standard for diagnosing Huntington's disease?

Nearly, with one important qualification. The genetic test is the gold standard for confirming that a person carries the cause of Huntington’s disease. The clinical diagnosis of Huntington’s disease itself is still made by a neurologist, based on characteristic movement signs in a person known to carry the expansion (Mayo Clinic). Those two things sound identical. They are not.

A person with 42 repeats and no symptoms is described as premanifest, meaning they carry the gene but have not yet developed the disease. They are not, in clinical terms, diagnosed with Huntington’s disease. The diagnosis is made when a specialist finds unequivocal motor signs: the involuntary dance-like movements called chorea, slowed or clumsy voluntary movement, or changes in eye movement and gait that the examiner is confident are not explained by anything else. Mood and cognitive changes often come first, but they are too non-specific on their own to anchor a diagnosis.

Brain imaging has a supporting role. MRI or CT scans may show shrinkage in parts of the striatum as the disease advances, and imaging helps rule out other causes such as stroke or tumor (Mayo Clinic). Imaging alone cannot diagnose Huntington’s disease, and a normal scan does not exclude it in the early years.

Why does the distinction matter for planning care? Because it governs timing. Treatment of symptoms begins when symptoms begin, not when the gene is found. Monitoring, by contrast, can begin whenever the person wants it. Many specialist services offer periodic review to premanifest adults who want a baseline and a relationship with a team before anything changes. Others prefer to stay away from clinics until they have a reason to attend. Both are reasonable.

What the days and weeks after a Huntington's test result usually look like

Counselors warn people that the first days after a result rarely feel the way they expected, whichever way the result went. That warning turns out to be one of the most useful things they say.

After a positive result, the early response is often numbness rather than grief. The grief tends to arrive in waves over the following weeks, frequently triggered by small things: a parent’s handwriting, a job advertisement, a child’s birthday. Sleep is commonly disturbed. Some people describe a strange relief at no longer living with uncertainty, and then feel guilty about the relief. Services schedule a follow-up within weeks precisely because the second and third conversations are often more productive than the first (NHS).

After a negative result, the surprise is how complicated it feels. People expect joy and often find it, but mixed with what counselors call survivor guilt, especially if a sibling has tested positive or a parent is declining. Relationships built around shared risk can shift. A few people feel oddly unmoored, having organized their adult identity around a future that has just evaporated.

The intermediate and reduced-penetrance bands bring their own version of this, because the answer was supposed to be yes or no and instead it is maybe, or not me but possibly my children.

Practically, the weeks after a result are a good time for a few concrete steps and a poor time for big irreversible ones. Deciding who in the family to tell, and in what order, is worth doing deliberately. Siblings in particular have a stake, because a positive result in one sibling confirms the parent’s diagnosis and the risk for all. Most counselors advise waiting on major decisions about work, relationships or moving house until the result has settled, which for many people is a matter of months rather than days.

A positive result: what it tells you about timing, and what it cannot

The hardest honest answer in this field is that the test says yes or no but almost never says when. People understandably want more, and it is worth being precise about what the evidence allows.

Adult-onset Huntington’s disease most often begins in a person’s 30s or 40s, with early signs that can include irritability, low mood, trouble with planning and small involuntary movements (MedlinePlus Genetics). Onset before age 20 is classed as juvenile Huntington’s disease, which tends to look different, with stiffness, slowness and sometimes seizures rather than prominent chorea, and is usually associated with very long repeats, often above 60 (MedlinePlus Genetics).

Within the adult range, a higher CAG count correlates with earlier onset when you look across thousands of people. Within one person it is a weak guide. Someone with 41 repeats may develop symptoms in their 60s or later; someone with 45 might begin in their late 30s. Other genes and factors not yet fully understood shift the timing by years in either direction. For this reason, reputable services do not give individuals a predicted age of onset from their repeat count.

What the evidence does say is that once symptoms begin, the disease progresses over many years. People with adult-onset disease live on average about 15 to 20 years after signs appear, and those with juvenile onset about 10 to 15 years (MedlinePlus Genetics). These are population averages drawn from an era before current supportive care was widespread, and individual courses vary.

Researchers are working on blood, spinal fluid and imaging markers that might one day signal how close a premanifest person is to onset. Those tools remain in research settings and are not part of standard predictive testing. A positive result today is best understood as a certainty about direction paired with real uncertainty about distance.

How is Huntington's disease managed once symptoms begin?

There is currently no treatment that stops or slows the underlying nerve-cell loss. Management is therefore about symptoms and function, and it works best when it is coordinated across several professions (Mayo Clinic). Which treatments are used, in what sequence and at what point, is decided by the treating team with the person and their family.

For movement symptoms, neurologists may consider medicines that reduce chorea. One class, known as VMAT2 inhibitors (generic examples include tetrabenazine and deutetrabenazine), works by lowering the amount of dopamine released at nerve endings, which calms the excess movement. Certain antipsychotic medicines are sometimes used for the same purpose and can also help with agitation or psychosis. All of these carry potential effects on mood, sleep and alertness, which is why decisions about them sit with the prescriber (Mayo Clinic).

Mood and behavior symptoms are common and often more disabling than movement in the early years. Depression, anxiety, irritability and obsessive thinking are typically addressed with a combination of psychological support and, where appropriate, antidepressant or mood-stabilizing medicines chosen by a psychiatrist or neurologist familiar with the condition (Mayo Clinic).

Beyond medicines, the evidence supports a set of therapies that most specialist clinics build in from the start:

• Physical therapy to maintain balance, strength and safe walking, and to reduce falls.
• Occupational therapy to adapt the home, simplify tasks and preserve independence.
• Speech and language therapy for speech clarity and, critically, for swallowing, since choking and aspiration become risks as the disease advances.
• Dietetic input, because involuntary movement burns calories and many people need a higher-energy diet to maintain weight (Mayo Clinic).

The thread running through all of this is anticipation in the ordinary sense of the word: planning for needs before they become emergencies.

Planning care after a result: from genetic counseling to a long-term team

A result on paper becomes useful only when it reshapes the years that follow. For a premanifest adult, planning tends to fall into four strands.

Clinical relationships. Many people choose to register with a neurology service that has experience with the condition, even while well, so that a baseline examination exists and a known team can be reached if something changes. Others prefer to wait. Either way, knowing where to go removes a layer of dread.

Family and reproductive conversations. A positive result means siblings are at 50 percent risk and any existing children are too. Genetic counseling is available to them in turn, and nobody should be tested, or told, without their consent. Couples planning a pregnancy can discuss prenatal, preimplantation and exclusion options with the genetics team, as described above (NHS).

Legal and financial groundwork. This is the strand people most often postpone and most often wish they had started earlier. Advance care planning, meaning documenting one’s wishes about future medical treatment and naming someone to speak on one’s behalf, is far easier while thinking is unaffected. Reviewing employment protections, pensions and insurance is part of this.

On that last point, people in the United States often ask about discrimination. Federal law under the Genetic Information Nondiscrimination Act prohibits most health insurers and employers from using genetic test results against a person. It does not cover life insurance, disability insurance or long-term care insurance, so some people choose to arrange those policies before testing (MedlinePlus Genetics). Rules differ in other countries, and a genetic counselor can explain the local position.

Community and research. Patient organizations and research registries give premanifest adults a way to contribute to trials and to meet others living with the same knowledge. For many people this turns a passive diagnosis into an active role.

What people often get wrong about Huntington's genetic testing

A condition this rare accumulates folklore. Several beliefs come up again and again in counseling rooms, and correcting them matters because they drive decisions.

“It skips a generation.” It does not. What looks like skipping is usually a parent who died early of something else, or who had reduced-penetrance repeats and never developed symptoms, or whose late-life changes were put down to aging (MedlinePlus Genetics).

“If I test negative, my children still need testing.” If a person’s larger allele is 26 or fewer, they cannot pass on an expansion, and their children are not at risk from that side of the family. The intermediate band, 27 to 35, is the exception, which is why counselors explain it even to people who test negative for the disease itself.

“Only fathers pass it on.” Mothers and fathers each pass it on with a 50 percent chance. The difference is that the repeat is more likely to lengthen when inherited through the father, which affects age of onset, not whether it is inherited (MedlinePlus Genetics).

“The test will tell me when I will get sick.” It will not. The repeat count correlates with onset across populations but cannot date it for an individual.

“A result of 36 to 39 means I definitely have it.” That range is reduced penetrance. Some people in it never develop symptoms.

“I can test my child to settle the family’s nerves.” Predictive testing in children without symptoms is not offered, because the result is irreversible and the child cannot consent (NHS).

“A consumer DNA kit already told me.” Ancestry and wellness kits do not measure CAG repeat length in the HTT gene. Any claim about Huntington’s status from such a kit should be checked with a clinical genetics service before it is believed or acted on.

Questions to ask your care team about Huntington's disease genetic testing

Good counseling sessions leave room for questions, but it is easy to go blank in the moment. People who have been through the process suggest writing these down beforehand and taking the list in.

• Has the diagnosis in my relative been confirmed by a genetic test, and if not, how will you confirm it before testing me?
• How many counseling sessions do you usually hold before the blood sample, and can I pause or stop at any stage?
• Will I have a neurological examination before predictive testing, and what would it mean if you found early signs?
• How will the result be given, who can be with me, and when is the follow-up appointment?
• If my result falls in the 27 to 35 or 36 to 39 range, what exactly would that mean for me and for my children?
• What support is available in the weeks after the result, for both a positive and a negative outcome?
• How should I think about telling siblings and children, and can you help with those conversations?
• What reproductive options exist, and does any of them require me to learn my own status?
• What are the insurance and employment protections where I live, and is there anything worth arranging before I test?
• If I test positive, what does monitoring look like, how often would you want to see me, and what signs should prompt an earlier appointment?
• Are there research studies or registries open to premanifest adults, and how would I join?
• Who do I contact if I change my mind about anything we have discussed?

The last question is not an afterthought. A testing process that leaves the door open in both directions is a mark of a service that understands what it is asking of people. If the answers to these questions feel rushed or dismissive, it is reasonable to ask for more time or a second conversation.

When to call your doctor

For a premanifest adult, the question is less about emergencies than about noticing change. A neurologist familiar with the condition would want to hear about new involuntary movements, a change in handwriting or coordination, unexplained falls, or a shift in mood and personality that the people around you have noticed, even if you have not. None of these on their own confirms onset, and all have other causes, which is exactly why they deserve an unhurried assessment rather than silent worry.

Depression deserves its own line. It is common both in people who carry the expansion and in the months after any result, and the risk of suicidal thinking is real in this community. Anyone thinking about harming themselves, or who finds that hopelessness has started to feel permanent, should contact their doctor the same day or use emergency services. This applies equally to people who have tested negative and are struggling with the aftermath.

For someone already living with symptoms, certain signs call for prompt medical contact rather than waiting for the next scheduled review:

• Choking episodes, coughing when swallowing, or a chest infection, because of the risk of food or fluid entering the lungs.
• Rapid or unexplained weight loss despite eating.
• A fall with head injury, or a sudden increase in falls.
• New confusion, severe agitation or hallucinations.
• High fever, marked muscle stiffness or sweating in someone taking medicines for movement or psychiatric symptoms; this combination needs urgent assessment.
• A sudden worsening of movement, speech or alertness over days rather than months.

Carers should trust their own judgment. The person who knows someone’s usual self is often the first to detect that something has shifted, and specialist teams would rather hear about a false alarm than miss a real one. Every decision about investigation and treatment rests with the treating clinicians, but the call that starts that process can come from anyone.

Frequently asked questions

Can genetic testing detect Huntington's disease before symptoms start?

Yes. Because the condition is caused by a measurable expansion of CAG repeats in the HTT gene, a blood test can identify carriers decades before symptoms. This is called predictive testing and is offered to adults with an affected relative after genetic counseling. The test shows whether the disease will develop but not when, which is why follow-up support is built into the process.

What is the gold standard test for diagnosing Huntington's disease?

The HTT gene test is the definitive way to confirm that a person carries the cause of Huntington’s disease. The clinical diagnosis itself is made by a neurologist who finds characteristic movement signs in someone with the expansion. Brain imaging can support the picture and rule out other causes, but imaging alone cannot diagnose the condition.

How is Huntington's disease genetically inherited?

It is autosomal dominant. One expanded copy of the HTT gene is enough to cause the disease, and each child of an affected parent has a 50 percent chance of inheriting it with every pregnancy. Men and women are affected equally. The repeat can lengthen when passed on, especially through fathers, which is linked to earlier onset in the next generation.

What does a CAG repeat count of 36 to 39 mean?

It falls in the reduced-penetrance range. Some people with 36 to 39 repeats develop Huntington’s disease, often later in life, and some never do. Nobody can currently predict which outcome applies to a given person. Because the repeat can expand when inherited, children of someone in this range may land in the full-penetrance range, so counseling covers family implications.

How long does Huntington's disease predictive testing take from first appointment to result?

The timeline is shaped by counseling, not laboratory speed. Most services hold one or more counseling sessions, sometimes weeks apart, before a blood sample is taken. Once the sample is sent, results typically return within a few weeks, according to the NHS. Results are given in person with a follow-up appointment arranged for both positive and negative outcomes.

Can children be tested for Huntington's disease?

Predictive testing is not usually offered to children under 18 who have no symptoms. The result would be irreversible, offers no medical benefit in childhood, and removes the young person’s right to choose as an adult. A child with clear symptoms suggestive of juvenile Huntington’s disease is different and may be tested diagnostically after specialist assessment.

How is Huntington's disease managed after diagnosis?

No treatment currently stops nerve-cell loss, so care focuses on symptoms and function. Neurologists may use medicines by class to reduce chorea or to treat mood and behavior changes, with all decisions resting with the prescribing team. Physical, occupational and speech therapy, swallowing assessment and nutrition support are standard parts of coordinated care.

Does a positive Huntington's test tell me when I will get sick?

No. Adult-onset symptoms most often begin in the 30s or 40s, and higher repeat counts correlate with earlier onset across large groups, but the spread for any individual is wide. Reputable services do not give a predicted age of onset from a repeat count. Research into blood, spinal fluid and imaging markers is ongoing but not part of routine testing.

Is Huntington's disease genetic counseling required before testing?

Specialist services treat it as an essential part of the process rather than an optional extra. Counseling confirms the family diagnosis, explains the four result ranges, explores reproductive and insurance implications, and gives people room to decide freely or to step back. Follow-up counseling after the result is equally standard, whatever the outcome.

Can a home ancestry DNA kit detect Huntington's disease?

No. Consumer ancestry and wellness kits do not measure the length of the CAG repeat in the HTT gene, which is the only way to determine Huntington’s status. Any suggestion about this condition from such a kit should be discussed with a clinical genetics service before being believed or acted upon.

References

• Huntington disease – MedlinePlus Genetics
• HTT gene – MedlinePlus Genetics
• Huntington's disease – NHS
• Can genetic testing lead to discrimination? – MedlinePlus Genetics

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.